Stockreport

PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com
PDF – Full-year 2025 product and royalty revenue of $831M, exceeding guidance –– Strong Sephience™ (sepiapterin) uptake since 2H 2025 launch with fourth quarter and 2025 rev [Read more]